Ardevora Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$10.6M Sell
182,900
-172,956
-49% -$9.23M 0.94% 58
2023
Q3
$18.8M Buy
+355,856
New +$18.7M 0.92% 39

Other funds holding BSX

Ardevora Asset Management's BSX Position: Q4 2023 in Review

Ardevora Asset Management reduced its Boston Scientific (BSX) stake by 49% in Q4 2023, selling an estimated $9.23M and leaving 182,900 shares worth $10.6M. The position accounts for 0.94% of the portfolio, ranked #58.

Ardevora Asset Management first reported a position in BSX in Q3 2023 and has held it in 2 quarters since. The position peaked at $18.8M in Q3 2023. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

  • Ardevora Asset Management held 182,900 shares of Boston Scientific worth $10.6M as of Q4 2023.
  • Ardevora Asset Management sold 172,956 Boston Scientific shares in Q4 2023, an estimated $9.23M.
  • Boston Scientific made up 0.94% of Ardevora Asset Management's portfolio in Q4 2023, its #58 holding.
  • Ardevora Asset Management first reported a position in Boston Scientific in Q3 2023 and has held it in 2 quarters since.
  • Ardevora Asset Management's Boston Scientific position peaked at $18.8M in Q3 2023.
  • 1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Ardevora Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.